Assuming monitoring is required, the following results were found.

  • Global Wearable Adhesive Market Growth, Trends, and Forecast Report 2019-2024 - ResearchAndMarkets.com - Business Wire

    stuck to the body, necessitating the design and development of new adhesives.Wearable products are used as handheld monitoring tools and have applications in identification and monitoring of diseases. Owing to the growth in chronic diseases, more...

    https://mschristian.org/index.php/blog/global-wearable-adhesive-market-growth-trends-and-forecast-report-2019-2024-researchandmarkets-com-business-wire
  • Global Wearable Adhesive Market Growth, Trends, and Forecast Report 2019-2024 - ResearchAndMarkets.com - Business Wire

    stuck to the body, necessitating the design and development of new adhesives. Wearable products are used as handheld monitoring tools and have applications in identification and monitoring of diseases. Owing to the growth in chronic diseases, more...

    https://mschristian.org/index.php/articles/2-uncategorised/9639-global-wearable-adhesive-market-growth-trends-and-forecast-report-2019-2024-researchandmarkets-com-business-wire
  • Researchers develop novel method to diagnose and monitor autoimmune disorders

    Academy of Sciences and the Moscow Institute of Physics and Technology have developed a novel method for diagnosing and monitoring autoimmune disorders. Within a mere 25 minutes, their new biosensor not only measures the concentration of autoantibodies...

    https://mschristian.org/index.php/researchers-develop-novel-method-to-diagnose-and-monitor-autoimmune-disorders
  • Gilenya (fingolimod) FDA approved

    medication in pill form * good safety profile, but some risks require consideration and monitoring * first dose usually give in doctors office * 1:200 risk of eye (macula) swelling * 1:200 risk of symptoms with slow heart rate on first dose * mild...

    https://mschristian.org/index.php/gilenya-fingolimod-fda-approved
  • FDA approves new drug that could aid MS diagnoses for clinical trials

    current standard-of-care imaging examination for MS, MRIs have long been used for diagnoses but are less effective for monitoring the disease. This drug may provide improved ongoing monitoring of brain health in general--and help doctors more accurately...

    https://mschristian.org/index.php/articles/2-uncategorised/9882-fda-approves-new-drug-that-could-aid-ms-diagnoses-for-clinical-trials
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    two late-stage studies on elenbecestat. The decision was taken following a safety review conducted by the Data Safety Monitoring Board. The board’s recommendation to discontinue the studies was due to unfavorable risk-benefit ratio. In March,...

    https://mschristian.org/index.php/articles/2-uncategorised/8852-biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • With COVID-19, Stroke Guidelines Now a 'Goal, Not an Expectation'

    in Stroke. Existing stroke guidelines regarding patient selection for therapy, treatment times, and post-recanalization monitoring should continue to be adhered to, the authors said. "However, we wish to inform regulatory authorities -- and we wish to...

    https://mschristian.org/index.php/blog/with-covid-19-stroke-guidelines-now-a-goal-not-an-expectation
  • From The CDC - Center for Disease Control : Coronavirus Disease 2019 (COVID-19)

    the impact of disease. Have a plan for if you get sick Consult with your health care provider for more information about monitoring your health for symptoms suggestive of COVID-19.Stay in touch with others by phone or email. You may need to ask for help...

    https://mschristian.org/index.php/blog/from-the-cdc-center-for-disease-control-coronavirus-disease-2019-covid-19
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    to be “4 for 4” in key factors that have a significant impact on this condition. Here’s what you can do: Initiating and Monitoring MS Therapy As the clinician, you should help the patient choose the most effective DMT they are comfortable taking. Forgo...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Potential genetic markers of multiple sclerosis severity

    researcher's findings, reported in the September issue of Brain, the investigators say they could serve as markers for monitoring and predicting progression and severity of MS, an unpredictable disorder in which the immune system eats away at protective...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • Researchers identify genes linked to most severe symptoms of multiple sclerosis

    researcher's findings, reported in the September issue of Brain, the investigators say they could serve as markers for monitoring and predicting progression and severity of MS, an unpredictable disorder in which the immune system eats away at protective...

    https://mschristian.org/index.php/blog/researchers-identify-genes-linked-to-most-severe-symptoms-of-multiple-sclerosis
  • Novel subtype of multiple sclerosis

    in MS and underscore the need for more sensitive MRI imaging techniques for evaluating brain pathology in real time and monitoring treatment response in patients with the disease. Cleveland Clinic researchers have discovered a new subtype of multiple...

    https://mschristian.org/index.php/blog/novel-subtype-of-multiple-sclerosis
  • Treating pediatric MS

    and expectations of the child and family, how the drug is expected to control the MS, the side effects, the risks and any monitoring (blood tests, MRI and other tests) after the therapy is started. In this way, providers, patients and families can...

    https://mschristian.org/index.php/blog/treating-pediatric-ms
  • Learn about Neurofilament light polypeptide

    plasma and reflects axonal damage in a wide variety of neurological disorders.[7][8] It is a useful marker for disease monitoring in amyotrophic lateral sclerosis,[9] multiple sclerosis,[10] Alzheimer's disease,[11][12] and more recently Huntington's...

    https://mschristian.org/index.php/blog/learn-about-neurofilament-light-polypeptide
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    two late-stage studies on elenbecestat. The decision was taken following a safety review conducted by the Data Safety Monitoring Board. The board’s recommendation to discontinue the studies was due to unfavorable risk-benefit ratio. In March,...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    ASCLEPIOS are wonderful news for patients who would like to take an effective B-cell therapy with low requirement for monitoring, avoiding visits to an infusion center.” “Ofatumumab, if approved, could be a highly attractive treatment option for a broad...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • Higher levels of serotonin after a seizure linked to lower incidence of breathing problems

    age of 42. Participants, who had been diagnosed with epilepsy for an average of 17 years, spent time in an epilepsy monitoring unit, where researchers examined one seizure for each participant, evaluating the electrical activity in the brain and the...

    https://mschristian.org/index.php/blog/higher-levels-of-serotonin-after-a-seizure-linked-to-lower-incidence-of-breathing-problems
  • Juul testing new Bluetooth-enhanced ‘lockable’ C1 device in UK market

    Juul C1 e-cigarette pairs with an Android smartphone via Bluetooth to limit who can use it as well as to provide a way of monitoring how often the user vapes, according to an article posted on bbc.com. The product, the first in a series of...

    https://mschristian.org/index.php/blog/juul-testing-new-bluetooth-enhanced-lockable-c1-device-in-uk-market
  • The $432B Medical Devices Market: Worldwide Trends, Forecasts and Competitive Analyses (2014-2025) - P&T Community

    geriatric population, inactive lifestyle, and poor eating habits. Within the medical device market, diagnostic and monitoring, therapeutic, and surgical are the major function segments. The surgical device will remain the largest segment over the...

    https://mschristian.org/index.php/articles/2-uncategorised/9751-the-432b-medical-devices-market-worldwide-trends-forecasts-and-competitive-analyses-2014-2025-p-t-community
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    to be “4 for 4” in key factors that have a significant impact on this condition. Here’s what you can do: Initiating and Monitoring MS Therapy As the clinician, you should help the patient choose the most effective DMT they are comfortable taking. Forgo...

    https://mschristian.org/index.php/articles/2-uncategorised/9438-treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction

Results 1 - 20 of 49